Episode Details

Intuitive Surgical’s stock is crashing — down 30% this year — but UBS is rallying behind it, upgrading the stock and setting a $500 price target, arguing the selloff is overblown. The bank believes automation will make robotic surgery faster and cheaper, boosting adoption and opening new markets like cardiac and lung procedures. Despite beating earnings and revenue, the stock dropped 12% after U.S. procedure growth slowed to 12% — a red flag for investors, even though management blamed policy shifts and deferred surgeries. Other firms like Truist and Raymond James have lowered targets but kept bullish ratings, while Goldman Sachs has stayed supportive all year — fueling a heated debate about whether the market is missing the bigger picture.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/31a84851e2b59dc0